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Study of Elements, Antioxidants and Lipid Peroxidation
in Hemodialysis Patients*
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Background: During hemodialysis, most of the elements must be kept in a rather narrow physiological range,
otherwise life-threatening events may occur. Furthermore, lipid peroxidation in patients may be partly due to
the trace element disturbances. It has been mentioned that there are relations between deficiency in trace
elements and antioxidant levels. The present study aimed to determine whether there were differences
between hemodialysis patients and a healthy group according to selenium, aluminium, malondialdehyde (MDA),
reduced form of glutathione (GSH) and superoxide dismutase (SOD) levels.
Methods: The study included 47 hemodialysis patients (hemodialysis group). Blood samples were taken
before (pre-hemodialysis) and after (post-hemodialysis) hemodialysis session. The control group included 23
healthy volunteers.
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Results: The aluminium, MDA, and SOD levels were lower and reduced form of GSH levels were higher in the
control group when compared with the pre-hemodialysis group. MDA and SOD levels were higher in the posthemodialysis group than in the control group. GSH levels were lower and aluminium levels higher in the preversus the post-hemodialysis group.
Conclusions: In order to evaluate the data of antioxidant and oxidant levels, hemodialysis patients are
subjected to oxidative stress. Moreover, the study shows that analyzing levels of aluminium may be useful in
hemodialysis patients in evaluating elements status.
Key Words: Hemodialysis, antioxidants, oxidants, selenium, aluminium

Hemodiyaliz Hastalar›nda Lipit Peroksidasyonu, Antioksidan ve Element
Düzeyleri
Giriﬂ ve Amaç: Hemodiyaliz s›ras›nda, birçok element oldukça dar fizyolojik aral›k içinde tutulmal›d›r ki, aksi
durumunda hayati tehlike görülebilir. Bunun yan›s›ra, bu hastalarda lipid peroksidasyonu, k›smen eser element
bozukluklar›ndan dolay› olabilmektedir .Eser elementlerin eksikli¤i ile antioksidan düzeyleri aras›nda iliﬂkinin
varl›¤›ndan sözedilmektedir. Sunulan çal›ﬂman›n amac›; selenyum, aluminyum, malondialdehit (MDA), redükte
glutatyon(GSH) ve superoksit dismutaz düzeyleri bak›m›ndan hemodiyaliz hastalar› ile sa¤l›kl› grup aras›nda
fark›n olup olmad›¤›n› belirlemek idi.
Yöntem ve Gereç: “Hemodiyaliz grubu” olarak tan›mlad›¤›m›z grup 47 hemodiyaliz hastas›ndan
oluﬂturulmuﬂtur. Kan numuneleri hemodiyalizden önce (pre-hemodiyaliz) ve sonra (post-hemodiyaliz) olmak
üzere toplanm›ﬂt›r. “Kontrol grubu” 23 sa¤l›kl› gönüllüden oluﬂmuﬂtur.
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Bulgular: Kontrol grubunda, pre-hemodiyaliz grubuna göre aluminyum, MDA, SOD düzeyleri düﬂük, ve
redükte GSh yüksek idi. MDA; SOD düzeyleri post-hemodiyaliz grubunda kontrol grubuna göre yüksekti.
Bunun yan›s›ra, pre-hemodiyaliz grubunda post-hemodiyaliz grubuna göre; GSH düzeyleri düﬂük, aluminyum
düzeyleri yüksekti.
Sonuç: Antioksidan ve oksidan düzeylerine ait veriler de¤erlendirildi¤inde, hemodiyaliz hastalar› oksidatif
strese maruz kalmaktad›r. Bununla birlikte, çal›ﬂma aluminyum düzeylerinin analizinin, hemodiyaliz
hastalar›n›n element durumlar›n›n de¤erlendirilmesinde yararl› olabilece¤ini göstermektedir.
Anahtar Sözcükler: Hemodiyaliz, antioksidan ve oksidanlar, selenyum, aluminyum
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Introduction

Materials and Methods

During hemodialysis (HD) essential kidney functions,
such as the elimination of water and metabolic wastes as
well as the correction of the electrolyte and acid/base
state, are replaced by the artificial purification system.
Elements such as Na+, K+, Ca++, Mg+, Cl-, and H+ must be
kept in a rather narrow physiological range, otherwise
life-threatening events may occur (1). Moreover, renal
impairment, anemia and other clinical complications in
hemodialysis patients may be commonly related to
increased cellular uptake and toxicity of aluminium (2-4),
whereas deficiencies may occur more commonly for iron,
zinc and possibly selenium and toxicities are possible for
copper (4).

This study involved 47 hemodialysis patients
(“hemodialysis group”, 34 female, 13 male) who were
treated in the Polyclinic of the Hemodialysis Department
of Nephrology in Selcuk University Medical Faculty. The
mean age of the patients was 50.26 ± 16.36 years. All
patients were dialyzed three times a week and each
session was at least four hours. They were dialyzed with
polysulfone dialyzing membrane. The duration of dialysis
ranged from 2-16 years. Patients with hepatitis B, acute
medical events, and aluminium-containing drug usage
were excluded from this study.

Dialysis patients are subjected to an oxidative stress
resulting from the dialysis sessions (5,6). Oxidative stress
occurs when there is an excessive free radical production
and/or low antioxidant defense (7,8), and results in
chemical alterations of bio-molecules, which cause
structural and functional modifications (7). Lipid
peroxidation often occurs in response to oxidative stress,
and a great diversity of aldehydes are formed when lipid
hydroperoxides break down in biological systems. Some
of these aldehydes are highly reactive and may be
considered as second toxic messengers, which
disseminate and augment initial free radical events.
Polyunsaturated fatty acids are oxidized in vivo by free
radicals and other reactive species. Subsequent
degradation of oxidized lipid molecules leads to the
formation of several specific metabolites that include
aldehydes of variable chain length, such as
malondialdehyde (9). Its consequences may be
aggravated by the concomitant lowering of the patient’s
defense system. This event occurs as a result of
disturbance in the detoxification enzyme system (e.g.
superoxide dismutase, SOD) that detoxifies free radicals
(5,6). Selenium and glutathione peroxidase (GSH-Px) play
an important role in protecting cell membranes from
oxidative damage, and decreased blood selenium and
GSH-Px activity are common in chronic renal failure
(CRF) (10).
We purposed to determine levels of aluminium and
selenium, malondialdehyde (MDA), SOD and reduced
form of GSH in hemodialysis patients and healthy
volunteers, and in addition to determine whether there
are any correlation coefficients of trace elements with
antioxidants and oxidants.
280

The control group was composed of 23 healthy
volunteers (7 female, 16 male) with a mean age of 39.52
± 11.54 years. Controls had no medical problems, and no
alcohol or cigarette consumption.
Samples Collection: Blood samples were taken from
the hemodialysis patients during their regular monthly
check-ups. No extra blood samples were taken from the
patients for the biochemical parameters investigated in
this study. Samples were collected immediately before
(pre-hemodialysis) and after (post-hemodialysis) the
dialysis sessions.
Samples from the control group were taken after a
10-hour fasting period. The control group was selected
from individuals presenting for their routine check-ups.
Extra blood samples were not taken.
Blood samples were divided into two tubes (with and
without anticoagulant -EDTA). The EDTA anticoagulant
samples were centrifuged at 2000 rpm for 10 min at +4
°C. Red cells were washed three times with ice-cold
normal saline solution. Erythrocyte SOD, reduced form of
GSH and plasma MDA were analyzed immediately after
taking blood samples.
Serum samples were stored into polyethylene tubes at
-85°C to analyze the levels of aluminium and selenium.
Elements levels were determined by inductively coupled
plasma atomic emission spectrometry (ICP-AES, Varian
Australia Pty Ltd, Australia). Plasma MDA and
erythrocyte-reduced form of GSH levels were determined
respectively according to the method of TBARS (11,12)
and Ellmann (13). SOD (catalog no: SD 125) levels were
analyzed by using Randox test kits in spectrophotometers
(Shimadzu-1601, Japan).
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Statistical Analysis: Data were expressed as mean ±
SD and analyzed with SPSS packet program. Student’s ttest and Mann-Whitney U test were used to compare the
groups. Pearson correlation coefficients were applied to
evaluate the relationship between levels of trace elements
and the other parameters. The level of statistical
significance was set at P < 0.001.

Results
Data concerning the hemodialysis and control groups
are shown in Table 1.
In pre-hemodialysis patients, the levels of aluminium,
MDA, and SOD (P < 0.001) were higher and reduced
form of GSH levels (P < 0.001) were lower than in
controls. There were no significant differences in
selenium levels between controls and the prehemodialysis values (Table 1).
While MDA and SOD levels were higher in patients
after hemodialysis than in the control group (P < 0.001),
we did not determine any significant differences in levels
of reduced form of GSH, selenium, or aluminium between
the control and post- hemodialysis groups.
Reduced form of GSH levels of post-hemodialysis
patients were higher (P < 0.001) and of aluminium were
lower (P < 0.001) than levels before the dialysis session.
In those groups, levels of SOD, MDA and selenium were
not significantly different.
In the control group, a positive correlation between
aluminium and selenium (r = 0.474), and in the post-

October 2006

hemodialysis patients a positive correlation between
selenium and aluminium (r = 0.571, P < 0.001),
selenium and MDA (r = 0.365, P < 0.05), MDA and
reduced form of GSH (r = 0.499, P < 0.001), and
reduced form of GSH and SOD (r = 0.865, P < 0.001)
were determined. In addition, a positive correlation
between levels of GSH and SOD (r = 0.420, P < 0.01)
was determined in the pre-hemodialysis group (data not
shown).

Discussion
Though trace elements occur in very low
concentrations in the body, their role in the maintenance
of undisturbed biological functions is nonetheless highly
important. Dialysis remarkably contributes to an increase
in the elemental body burden of many elements. In CRF,
the concentrations of trace elements are modified partly
as a consequence of endogenous toxicities and of
impaired renal function, partly due to dietary restriction
and, last but not least, due to therapeutic measures (i.e.
conservative and modern instrumental therapy) (14).
Whereas some researchers have concluded that zinc
and selenium deficits in uremic patients were correlated
with disturbance in the enzyme systems which detoxify
free radicals (5), other researchers (15) have mentioned
that the essential trace element selenium might take part
not only in the direct protection of endothelial cells
against the accumulation of aggressive oxygen species,
but also in the prevention of the toxic effects of cadmium
or in the modulation of the active calcium transport (15).

Table 1. Parameter levels in control and hemodialysis groups (x ± SD).
GROUPS

P VALUES

Parameters
Control
(A)
SOD (U/g Hb)

995.84 ± 58.88

Pre-hemodialysis
(B)

Post-hemodialysis
(C)

4127.52 ± 238.50 5360.73 ± 762.82

A vs B

A vs C

B vs C

0.000*

0.000*

0.475

GSH (µmol/g Hb)

5.30 ± 0.24

4.56 ± 0.38

6.55 ± 0.51

0.001*

0.211

0.000*

MDA(nmol/ml)

6.97 ± 0.07

10.27 ± 0.18

11.05 ± 0.30

0.000*

0.000*

0.073

Selenium (µg/dl)

26 ± 1.18

26 ± 0.85

24 ± 1.42

0.93

0.93

0.41

Aluminium (µg/dl)

3.1 ± 0.17

4.60 ± 0.18

3.73 ± 0.18

0.000*

0.051

0.001*

* P < 0.001
SOD: Superoxide dismutase. GSH: Reduced form of glutathione. MDA: Malondialdehyde.
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In this respect, more careful attention is necessary in
analyzing the levels of selenium and zinc in regularly
dialyzed uremic patients (14).
Data obtained in the present study concerning
selenium levels in control and post-hemodialysis patients
are inconsistent with results presented by Richard et al.
(5), Turan et al. (15), Zima et al. (16) and Lin et al. (17),
but are consistent with those of Bogye et al. (18). Bogye
et al. suggested that there was no significant difference
between serum selenium concentration before and after
HD session. Turan, Zima and Lin (15-17) based on their
data suggested that selenium was lost through the pores
of polysulfone membrane during HD, which was
associated with its protein permeability. On the other
hand, Krizek et al. (19) measured the greatest changes in
blood selenium levels in post-hemodialysis patients
dialyzed with cuprophane membranes. Therefore, the
type of dialytic treatment could play a role in determining
the effective amounts of the elements which are
transferred from the dialysis fluid into the patient (14).
Thus, in order to clarify the selenium lost, it may be
useful to analyze the levels of selenium in dialysis fluid in
addition to that in blood samples.
Vanholder et al. (3) stated that decreased element
concentrations are related mainly to nutritional intake,
intestinal uptake and altered distribution and, in addition,
that protein-bound trace elements may be lost more
readily in presence of proteinuria. Increased trace
element concentrations can result from excessive
homeopathic intake, administration of parenteral fluids
or blood contact with contaminated dialysate (3).
Furthermore, uremic compounds may be related to
accumulation of aluminium. Thus, our results, which
show that aluminium levels are higher in HD patients than
in the control group, are consistent with those studies
(2,3,17,20).
Recent studies have suggested that lipid peroxidation
in patients may be due only in part to the trace element
disturbances (17) and that there are relations between
trace elements deficiency and antioxidant levels. In CRF
patients, disturbances in enzymatic mechanisms of free
radicals detoxification lead to alteration in the antioxidant
system (5,17) and ROS (reactive oxygen species) attack
on cell membranes also results in formation of lipid
peroxidation products such as MDA (21).
Researchers (8,25) have reported that forming free
radicals increased lipid peroxidation in CRF patients and
282
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together with dialysis was associated with an impairment
of antioxidant defense and an overproduction of oxidative
stress markers. Data that show the levels of MDA in all
groups in our study are consistent with those studies
(5,8,17,21-26) but not with Seymen et al.’s (27).
Defense mechanisms involve enzymes (which scavenge
the intermediates of oxygen reduction), elements such as
selenium, copper, zinc (which are present in the enzymes
SOD and GSH-Px), and substances such as vitamins E, C
and A (which defend against peroxidation of fatty acids)
(28). In some studies (23-24,26), SOD levels were higher
in pre-hemodialysis patients than in the control group.
Thus, our results are consistent with those data, but not
with the results of Hasano¤lu et al. (20), Seymen et al.
(27) and Chen et al. (29).
Meanwhile, protection from oxidant injury involves
numerous enzymatic and nonenzymatic pathways. One of
the most important nonenzymatic protective mechanisms
involves the glutathione pathway (21). Reduced GSH is
one of the most important scavengers of free radicals in
the red blood cell membrane (28). In the absence of an
efficient GSH-generating system, GSH cannot be
maintained in the reduced state when subjected to
oxidative stress (21). In this regard, our data concerning
reduced form of GSH when comparing controls and prehemodialysis patients are similar with the results of the
researchers (21,23-26,30). However, our results
comparing pre- and post-hemodialysis patient groups
regarding reduced form of GSH levels are not similar with
the results of the researchers (26). In addition, the study
(27) performed on the effect of the different dialytic
membranes on antioxidant levels determined no
significant differences between pre-and post-hemodialysis
groups in total GSH levels when using polysulfone
membrane. They suggested that the oxidant/ antioxidant
system did not statistically change in polysulfone
membrane, while hemodialysis patients dialyzed with the
cuprophane membrane demonstrated a statistically
significant disturbance in the oxidant/antioxidant enzyme
system.
Current studies present varying results regarding the
relation between antioxidant, oxidant and element levels
in hemodialysis patients. Those differences can be
attributed to variation in inclusion criteria to the study
(number of subjects, duration of dialysis range), timing of
blood sample collections and especially to the dialysis
membrane.
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Conclusion
Our findings show that levels of aluminium are
statistically different between groups and suggest that it
may be important to analyze this element. The abnormal
metabolism of aluminium may contribute to a part of
hemodialysis. Therefore, the study points out a significant
correlation between the levels of aluminium and
selenium. We think that environmental conditions, dialytic
treatment, and diet may affect the trace elements
metabolism in HD patients. Analyzing the levels of trace
elements not only in the blood samples but also in the
dialytic fluids may be more useful to clarify the effects of
elements in HD patients.
According to results of antioxidant and oxidant levels in
controls and pre-hemodialysis patients, finding decreased
levels of reduced form of GSH, and increased MDA and
SOD levels in pre-hemodialysis patients should be taken
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into consideration. We suggest that HD patients are
subjected to oxidative stress, as indicated by increased lipid
peroxidation and reduced antioxidant levels. But, when we
estimate the levels of SOD, GSH and MDA in pre- and posthemodialysis patients, it seems the relations of SOD and
MDA in hemodialysis patients before and after the dialysis
session must be investigated more extensively to clarify the
changes in the oxidant/antioxidant defense system during
the dialysis session.
Thus, seen from this aspect, the present study is
important but not extensive in determining the relation
between antioxidant and elements levels in the role of
disease physiopathology and in acceptable treatment. We
conclude that routine determination of those biochemical
parameter levels in hemodialysis patients may contribute
in monitoring the disease as well as any deficiency or
excess in those parameters.
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